LifeTech Scientific Corporation released its earnings results on Aug 29, 2025. The company reported HK$0.014 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.014.

Is LifeTech Scientific Corporation overvalued?

According to Wall Street analysts LifeTech Scientific Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LifeTech Scientific Corporation pay dividends?

LifeTech Scientific Corporation does not currently pay dividends.

What is LifeTech Scientific Corporation’s EPS estimate?

LifeTech Scientific Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LifeTech Scientific Corporation have?

LifeTech Scientific Corporation has 4,631,712,400 shares outstanding.

What happened to LifeTech Scientific Corporation’s price movement after its last earnings report?

LifeTech Scientific Corporation reported an EPS of HK$0.014 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.01%.

Which hedge fund is a major shareholder of LifeTech Scientific Corporation?

Currently, no hedge funds are holding shares in HK:1302

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

LifeTech Scientific Corporation Stock Smart Score

Neutral

Analyst Consensus

Hold

Average Price Target:
― (―)

Technicals

Fundamentals

Return on Equity

1.98%

Trailing 12-Months

Asset Growth

12.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

LifeTech Scientific Corporation

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.